SEARCH

SEARCH BY CITATION

Current Awareness

  • 1. Reviews
  • Special issue on: The discovery and development of the green fluorescent protein, GFP. Chem Soc Rev 38, (2009)
  • Gindy ME, Prud'homme RK. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv 6, 865-878 (2009)
  • Giovannini M. Contrast-enhanced endoscopic ultrasound and elastosonoendoscopy. Best Pract Res Clin Gastroenterol 23, 767-779 (2009)
  • Greis C. Ultrasound contrast agents as markers of vascularity and microcirculation. Clin Hemorheol Microcirc 43, 1-9 (2009)
  • Kaneda MM, Caruthers S, Lanza GM, Wickline SA. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Ann Biomed Eng 37, 1922-1933 (2009)
  • Kannan P, John C, Zoghbi SS, Halldin C, Gottesman MM, Innis RB, Hall MD. Imaging the function of P-glycoprotein with radiotracers: Pharmacokinetics and in vivo applications. Clin Pharmacol Ther 86, 368-377 (2009)
  • Koopmans KP, Neels ON, Kema IP, Elsinga PH, Links TP, De Vries EGE, Jager PL. Molecular imaging in neuroendocrine tumors: Molecular uptake mechanisms and clinical results. Crit Rev Oncol/Hematol 71, 199-213 (2009)
  • Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol 4, 627-633 (2009)
  • Mees G, Dierckx R, Vangestel C, Van de Wiele C. Molecular imaging of hypoxia with radiolabelled agents. Eur J Nucl Med Mol Imaging 36, 1674-1686 (2009)
  • O'Connor M, Rhodes D, Hruska C. Molecular breast imaging. Expert Rev Anticancer Ther 9, 1073-1080 (2009)
  • Oyen WJG, Van der Graaf WTA. Molecular imaging of solid tumors: Exploiting the potential. Nat Rev Clin Oncol 6, 609-611 (2009)
  • Pike VW. PET radiotracers: Crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol Sci 30, 431-440 (2009)
  • Soenen SJH, De Cuyper M. Assessing cytotoxicity of (iron oxide-based) nanoparticles: An overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol Imaging 4, 207-219 (2009)
  • Contrast Agents: 3. Chemistry
  • Aviv H, Bartling S, Kieslling F, Margel S. Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications. Biomaterials 30, 5610-5616 (2009)
  • Barick KC, Aslam M, Lin YP, Bahadur D, Prasad PV, Dravid VP. Novel and efficient MR active aqueous colloidal Fe3o4 nanoassemblies. J Mater Chem 19, 7023-7029 (2009)
  • Chen DX, Sun N, Gu HC. Size analysis of carboxydextran coated superparamagnetic iron oxide particles used as contrast agents of magnetic resonance imaging. J Appl Phys 106, 063906 (2009)
  • Ferreira MF, Martins AF, Martins JA, Ferreira PM, Toth E, Geraldes CFGC. Gd(DO3A-N-α-aminopropionate): A versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents. Chem Commun 6475-6477 (2009)
  • Hu KW, Liu TM, Chung KY, Huang KS, Hseih CT, Sun CK, Yeh CS. Efficient near-IR hyperthermia and intense nonlinear optical imaging contrast on the gold nanorod-in-shell nanostructures. J Am Chem Soc 131, 14186-14187 (2009)
  • Hun X, Bai L. Synthesis of folate conjugated fluorescent nanoparticle probe and its application in cervical cancer cell imaging. Anal Lett 42, 2280-2292 (2009)
  • Jeon BS, Cho EJ, Yang HM, Suh JS, Huh YM, Kim JD. Controlled aggregates of magnetite nanoparticles for highly sensitive MR contrast agent. J Nanosci Nanotechnol 9, 7118-7122 (2009)
  • Joshi HM, Lin YP, Aslam M, Prasad PV, Schultz-Sikma EA, Edelman R, Meade T, Dravid VP. Effects of shape and size of cobalt ferrite nanostructures on their MRI contrast and thermal activation. J Phys Chem C 113, 17761-17767 (2009)
  • Joshi NS, Bansal PN, Stewart RC, Snyder BD, Grinstaff MW. Effect of contrast agent charge on visualization of articular cartilage using computed tomography: Exploiting electrostatic interactions for improved sensitivity. J Am Chem Soc 131, 13234-13235 (2009)
  • Kahakachchi CL, Moore DA. Speciation of gadolinium in gadolinium-based magnetic resonance imaging agents by high performance liquid chromatography inductively coupled plasma optical emission spectrometry. J Anal Atom Spectrom 24, 1389-1396 (2009)
  • Kim DH, Rozhkova EA, Rajh T, Bader SD, Novosad V. Synthesis of hybrid gold/iron oxide nanoparticles in block copolymer micelles for imaging, drug delivery, and magnetic hyperthermia. IEEE Trans Magn 45, 4821-4824 (2009)
  • Makino A, Kizaka-Kondoh S, Yamahara R, Hara I, Kanzaki T, Ozeki E, Hiraoka M, Kimura S. Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide. Biomaterials 30, 5156-5160 (2009)
  • Richard C, Chaumet-Riffaud P, Belland A, Parat A, Contino-Pepin C, Bessodes M, Schermann D, Pucci B, Mignet N. Amphiphilic perfluoroalkyl carbohydrates as new tools for liver imaging. Int J Pharm 379, 301-308 (2009)
  • Sonoda A, Nitta N, Ohta S, Seko A, Jo J, Morikawa S, Tabata Y, Takahashi M, Murata K. Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging. Eur J Radiol 71, 570-575 (2009)
  • Thorek DLJ, Elias DR, Tsourkas A. Comparative analysis of nanoparticle-antibody conjugations: Carbodiimide versus click chemistry. Mol Imaging 8, 221-229 (2009)
  • Tsai ZT, Wang JF, Kuo HY, Shen CR, Wang JJ, Yen TC. In situ preparation of high relaxivity iron oxide nanoparticles by coating with chitosan: A potential MRI contrast agent useful for cell tracking. J Magn Magn Mater 322, 208-213 (2010)
  • Werner EJ, Botta M, Aime S, Raymond KN. Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents. Contrast Media Mol Imaging 4, 220-229 (2009)
  • Zhou JH, Huang L, Wang WW, Pang J, Zou Y, Shuai XT, Gao X. Prostate cancer targeted MRI nanoprobe based on superparamagnetic iron oxide and copolymer of poly(ethylene glycol) and polyethyleneimine. Chin Sci Bull 54, 3137-3146 (2009)
  • 4. Technique
  • Ali MM, Yoo B, Pagel MD. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol Pharmacol 6, 1409-1416 (2009)
  • Amor N, Zanker PP, Blumler P, Meise FM, Schreiber LM, Scholz A, Schmiedeskamp J, Spiess HW, Munnemann K. Magnetic resonance imaging of dissolved hyperpolarized 129Xe using a membrane-based continuous flow system. J Magn Reson 201, 93-99 (2009)
  • Arvanitis CD, Speller R. Quantitative contrast-enhanced mammography for contrast medium kinetics studies. Phys Med Biol 54, 6041-6064 (2009)
  • Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: A comparison in healthy volunteers. Acta Radiol 50, 709-715 (2009)
  • Calisir C, Yavas US, Kebapci M, Korkmaz A, Ozkan R. Contribution of the amount of contrast media used in pulmonary CT angiography to assess the diagnostic value of CT venography: Comparison of 100 and 150 ml of contrast media. Clin Radiol 64, 912-917 (2009)
  • Chen JS, Hunter KS, Shandas R. Wave scattering from encapsulated microbubbles subject to high-frequency ultrasound: Contribution of higher-order scattering modes. J Acoust Soc Am 126, 1766-1775 (2009)
  • Cheng HLM. Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach. J Magn Reson Imaging 30, 864-872 (2009)
  • Connelly KA, Detsky JS, Graham JJ, Paul G, Vijayaragavan R, Dick AJ, Wright GA. Multicontrast late gadolinium enhancement imaging enables viability and wall motion assessment in a single acquisition with reduced scan times. J Magn Reson Imaging 30, 771-777 (2009)
  • Crocco M, Pellegretti P, Sciallero C, Trucco A. Combining multi-pulse excitation and chirp coding in contrast-enhanced ultrasound imaging. Meas Sci Technol 20, 104017 (2009)
  • Cui YF, Tan YQ, Zhao BS, Liberman L, Parbhu R, Kaplan J, Theodoulou M, Hudis C, Schwartz LH. Malignant lesion segmentation in contrast-enhanced breast MR images based on the marker-controlled watershed. Med Phys 36, 4359-4369 (2009)
  • Danila D, Partha R, Elrod DB, Lackey M, Casscells SW, Conyers JL. Antibody-labeled liposomes for CT imaging of atherosclerotic plaques in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography. Tex Heart Inst J 36, 393-403 (2009)
  • Detsky JS, Paul G, Dick AJ, Wright GA. Reproducible classification of infarct heterogeneity using fuzzy clustering on multicontrast delayed enhancement magnetic resonance images. IEEE Trans Med Imaging 28, 1606-1614 (2009)
  • Dharmakumar R, Zhang ZL, Koktzoglou I, Tsaftaris SA, Li DB. Dual-contrast cellular magnetic resonance imaging. Mol Imaging 8, 254-263 (2009)
  • Egeland TAM, Simonsen TG, Gaustad JV, Gulliksrud K, Ellingsen C, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of tumors: Preclinical validation of parametric images. Radiat Res 172, 339-347 (2009)
  • Giakos GC, Valluru K, Adya V, Ambadipudi K, Paturi S, Bathini P, Becker M, Farajipour P, Marotta S, Paxitzis J, Mandadi B, Zervakis M, Livanos G. Stokes parameter imaging of multi-index of refraction biological phantoms utilizing optically active molecular contrast agents. Meas Sci Technol 20, 104003 (2009)
  • Goldfarb JW, Arnold S, Roth M. Gadolinium pharmacokinetics of chronic myocardial infarcts: Implications for late gadolinium-enhanced infarct imaging. J Magn Reson Imaging 30, 763-770 (2009)
  • Gong JS, Zhao H, Liu T, Ling RN, Xu JM. Value of MRCP using oral Gd-DTPA as negative contrast materials in diagnosis of atypical juxtapapillary duodenal diverticulum. Clin Imaging 33, 361-364 (2009)
  • Haberland U, Cordes J, Lell M, Abolmaali N, Klotz E. A biological phantom for contrast-media-based perfusion studies with CT. Invest Radiol 44, 676-682 (2009)
  • Hu Y, Chen Q, Ding Y, Li RT, Jiang XQ, Liu BR. Entering and lighting up nuclei using hollow chitosan-gold hybrid nanospheres. Adv Mater 21, 3639-3643 (2009)
  • Hwang DW, Ko HY, Kim SK, Kim D, Lee DS, Kim S. Development of a quadruple imaging modality by using nanoparticles. Chemistry 15, 9387-9393 (2009)
  • Hyodo F, Chandramouli GVR, Matsumoto S, Matsumoto KI, Mitchell JB, Krishna MC, Munasinghe JP. Estimation of tumor microvessel density by MRI using a blood pool contrast agent. Int J Oncol 35, 797-804 (2009)
  • Jung EM, Schreyer AG, Schacherer D, Menzel C, Farkas S, Loss M, Feuerbach S, Zorger N, Fellner C. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: First results. Clin Hemorheol Microcirc 43, 57-69 (2009)
  • Kalantarinia K, Belcik JT, Patrie JT, Wei K. Real-time measurement of renal blood flow in healthy subjects using contrast-enhanced ultrasound. Am J Physiol 297, F1129-F1134 (2009)
  • Kelm BM, Menze BH, Nix O, Zechmann CM, Hamprecht FA. Estimating kinetic parameter maps from dynamic contrast-enhanced MRI using spatial prior knowledge. IEEE Trans Med Imaging 28, 1534-1547 (2009)
  • Kim JS, An H, Rieter WJ, Esserman D, Taylor-Pashow KML, Sartor RB, Lin W, Lin W, Tarrant TK. Multimodal optical and Gd-based nanoparticles for imaging in inflammatory arthritis. Clin Exp Rheumatol 27, 580-586 (2009)
  • Kuhn JP, Hegenscheid K, Siegmund W, Froehlich CP, Hosten N, Puls R. Normal dynamic MRI enhancement patterns of the upper abdominal organs: Gadoxetic acid compared with gadobutrol. Am J Roentgenol 193, 1318-1323 (2009)
  • Lee ESM, Chan J, Shuter B, Tan LG, Chong MSK, Ramachandra DL, Dawe GS, Ding J, Teoh SH, Beuf O, Briguet A, Tam KC, Choolani M, Wang SC. Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging. Stem Cells 27, 1921-1931 (2009)
  • Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL, Wang LF. Folic acid-pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials 30, 5114-5124 (2009)
  • Lorch M, Thomasson MJ, Diego-Taboada A, Barrier S, Atkin SL, Mackenzie G, Archibald SJ. MRI contrast agent delivery using spore capsules: Controlled release in blood plasma. Chem Commun6442-6444 (2009)
  • Ma LL, Feldman MD, Tam JM, Paranjape AS, Cheruku KK, Larson TA, Tam JO, Ingram DR, Paramita V, Villard JW, Jenkins JT, Wang T, Clarke GD, Asmis R, Sokolov K, Chandrasekar B, Milner TE, Johnston KP. Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy. ACS Nano 3, 2686-2696 (2009)
  • Mascheri N, Dharmakumar R, Zhang ZL, Paunesku T, Woloschak G, Li DB. Fast low-angle positive contrast steady-state free precession imaging of USPIO-labeled macrophages: Theory and in vitro experiments. Magn Reson Imaging 27, 961-969 (2009)
  • Mendichovszky IA, Cutajar M, Gordon I. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study. Eur J Radiol 71, 576-581 (2009)
  • Motosugi U, Ichikawa T, Sou H, Sano K, Ichikawa S, Tominaga L, Araki T. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI). J Magn Reson Imaging 30, 849-854 (2009)
  • Naehle CP, Muller A, Willinek WA, Meyer C, Hestermann T, Gieseke J, Schild H, Thomas D. First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosvet trisodium. J Magn Reson Imaging 30, 809-816 (2009)
  • Ogura A, Hayakawa K, Miyati T, Maeda F. Effects of iodinated contrast agent on diffusion weighted magnetic resonance imaging. Acad Radiol 16, 1196-1200 (2009)
  • Patil V, Johnson G, Jensen JH. Robust quantification of contrast agent (CA) concentration with magnetic field correlation (MFC) imaging. Magn Reson Med 62, 1002-1106 (2009)
  • Peters DC, Appelbaum EA, Nezefat R, Dokhan B, Han YC, Kissinger KV, Goddu B, Manning WJ. Left ventricular infarct size, peri-infarct zone, and papillary scar measurements: A comparison of high-resolution 3D and conventional 2D late gadolinium enhancement cardiac MR. J Magn Reson Imaging 30, 794-800 (2009)
  • Quarles CC, Gochberg DF, Gore JC, Yankeelov TE. A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation. Phys Med Biol 54, 5749-5766 (2009)
  • Sabharwal N, Holland EC, Vazquez M. Live cell labeling of glial progenitor cells using targeted quantum dots. Ann Biomed Eng 37, 1967-1973 (2009)
  • Sanchez TA, Elias J, Colnago LA, Troncon LED, De Oliveira RB, Baffa O, De Araujo DB. Clinical feasibility of acai (Euterpe oleracea) pulp as an oral contrast agent for magnetic resonance cholangiopancreatography. J Comput Assist Tomogr 33, 666-671 (2009)
  • Saracco A, Aspelin P, Leifland K, Themudo R, Wilczek B, Axelsson R. Bolus compared with continuous infusion of microbubble contrast agent using real-time contrast harmonic imaging ultrasound in breast tumors. Acta Radiol 50, 854-859 (2009)
  • Sawant RM, Sawant RR, Gultepe E, Nagesha D, Papahadjopoulos-Sternberg B, Sridhar S, Torchilin VP. Nanosized cancer cell-targeted polymeric immunomicelles loaded with superparamagnetic iron oxide nanoparticles. J Nanopart Res 11, 1777-1785 (2009)
  • Seifarth H, Puesken M, Kalafut JF, Wienbeck S, Wessling J, Maintz D, Heindel W, Juergens KU. Introduction of an individually optimized protocol for the injection of contrast medium for coronary CT angiography. Eur Radiol 19, 2373-2382 (2009)
  • Siversson C, Tiderius CJ, Dahlberg L, Svensson J. Local flip angle correction for improved volume T1-quantification in three-dimensional dGEMRIC using the Look-Locker technique. J Magn Reson Imaging 30, 834-841 (2009)
  • Sur S, Mamisch TC, Hughes T, Kim YJ. High resolution fast T1 mapping technique for dGEMRIC. J Magn Reson Imaging 30, 896-900 (2009)
  • Terreno E, Stancanello J, Longo D, Delli Castelli D, Milone L, Sanders HMHF, Kok MB, Uggeri F, Aime S. Methods for an improved detection of the MRI-CEST effect. Contrast Media Mol Imaging 4, 237-247 (2009)
  • Van Buul GM, Farrell E, Kops N, Van Tiel ST, Bos PK, Weinans H, Krestin GP, Van Osch GJVM, Bernsen MR. Ferumoxides-protamine sulfate is more effective than ferucarbotran for cell labeling: Implications for clinically applicable cell tracking using MRI. Contrast Media Mol Imaging 4, 230-236 (2009)
  • Wang XX, Qu F, Chen ZB, Liang T, Ou AL. Labeling and imaging of GLUT4 in live L6 cells with quantum dots. Biochem Cell Biol 87, 687-694 (2009)
  • Weber PW, Coursey CA, Howle LE, Nelson RC, Nichols EB, Schindera ST. Modifying peripheral IV catheters with side holes and side slits results in favorable changes in fluid dynamic properties during the injection of iodinated contrast material. Am J Roentgenol 193, 970-977 (2009)
  • Xu FH, Cheng CM, Xu FJ, Zhang CF, Xu H, Xie X, Yin DZ, Gu HC. Superparamagnetic magnetite nanocrystal clusters: A sensitive tool for MR cellular imaging. Nanotechnology 20, 405102 (2009)
  • Yukawa H, Mizufune S, Mamori C, Kagami Y, Oishi K, Kaji N, Okamoto Y, Takeshi M, Noguchi H, Baba Y, Hamaguchi M, Hamajima N, Hayashi S. Quantum dots for labeling adipose tissue-derived stem cells. Cell Transplant 18, 591-599 (2009)
  • Zhang JL, Rusinek H, Bokacheva L, Chen Q, Storey P, Lee VS. Use of cardiac output to improve measurement of input function in quantitative dynamic contrast-enhanced MRI. J Magn Reson Imaging 30, 656-665 (2009)
  • Zheng LJ, Tu J, Chen WZ. Modeling of ultrasound contrast agents bubble dynamics with modified surface tension coefficient. Chin Sci Bull 54, 3501-3507 (2009)
  • 5. Experimental
  • Al-Jamal WT, Al-Jamal KT, Cakebread A, Halket JM, Kostarelos K. Blood circulation and tissue biodistribution of lipid-quantum dot (L-QD) hybrid vesicles intravenously administered in mice. Bioconjug Chem 20, 1696-1702 (2009)
  • Beaumont M, Lemasson B, Farion R, Segebarth C, Remy C, Barbier EL. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. J Cereb Blood Flow Metab 29, 1714-1726 (2009)
  • Blockley NP, Francis ST, Gowland PA. Perturbation of the BOLD response by a contrast agent and interpretation through a modified balloon model. Neuroimage 48, 84-93 (2009)
  • Buyukhatipoglu K, Miller TA, Clyne AM. Flame synthesis and in vitro biocompatibility assessment of superparamagnetic iron oxide nanoparticles: Cellular uptake, toxicity and proliferation studies. J Nanosci Nanotechnol 9, 6834-6843 (2009)
  • Deleo MJ, Gounis MJ, Hong B, Ford JC, Wakhloo AK, Bogdanov AA. Carotid artery brain aneurysm model: In vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study. Radiology 252, 696-703 (2009)
  • Fiandaca MS, Varenika V, Eberling J, McKnight T, Bringas J, Pivirotto P, Beyer J, Hadaczek P, Bowers W, Park J, Federoff H, Forsayeth J, Bankiewicz KS. Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage 47, T27-T35 (2009)
  • Ge YQ, Zhang Y, Xia JG, Ma M, He SY, Nie F, Gu N. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. Colloid Surface B 73, 294-301 (2009)
  • Hu SL, Zhang JQ, Hu X, Hu R, Luo HS, Li F, Xia YZ, Li JT, Lin JK, Zhu G, Feng H. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles. J Cell Biochem 108, 529-535 (2009)
  • Keilholz SD, Bozlar U, Fujiwara N, Mata JF, Berr SS, Corot C, Hagspiel KD. MR diagnosis of a pulmonary embolism: Comparison of P792 and Gd-DOTA for first-pass perfusion MRI and contrast-enhanced 3D MRA in a rabbit model. Korean J Radiol 10, 447-454 (2009)
  • Lee SI, Lee SY, Yoon KH, Choi KS, Jang KY, Yoo WH, Kim SH, Choi TH, Park JG. Molecular MR imaging for visualizing ICAM-1 expression in the inflamed synovium of collagen-induced arthritic mice. Korean J Radiol 10, 472-480 (2009)
  • Liu CH, Ren JQ, Yang JS, Liu CM, Mandeville JB, Rosen BR, Bhide PG, Yanagawa Y, Liu PK. DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains. J Neurosci 29, 10663-10670 (2009)
  • Loveless ME, Whisenant JG, Wilson K, Lyshchik A, Sinha TK, Gore JC, Yankeelov TE. Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model. Mol Imaging 8, 187-198 (2009)
  • Modo M, Beech JS, Meade TJ, Williams SCR, Price J. A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage 47, T133-T142 (2009)
  • Rahim NAA, McDaniel W, Bardon K, Srinivasan S, Vickerman V, So PTC, Moon JH. Conjugated polymer nanoparticles for two-photon imaging of endothelial cells in a tissue model. Adv Mater 21, 3492-3496 (2009)
  • Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Murata S, Jo J, Tabata Y, Takahashi M, Tani T, Murata K. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug. J Magn Reson Imaging 30, 907-910 (2009)
  • Tambalo S, Daducci A, Fiorini S, Boschi F, Mariani M, Marinone M, Sbarbati A, Marzola P. Experimental protocol for activation-induced manganese-enhanced MRI (AIM-MRI) based on quantitative determination of Mn content in rat brain by fast T1 mapping. Magn Reson Med 62, 1080-1084 (2009)
  • Xing YQ, Hou BW, Zhang Y, Liu XQ, Gao HQ. Comparison of adenosine stress and dobutamine stress by real-time myocardial contrast echocardiography in detecting myocardium ischemia in dogs. Chin Med J 122, 2002-2007 (2009)
  • Xuan JW, Bygrave M, Valiyeva F, Moussa M, Izawa JI, Bauman GS, Klibanov A, Wang F, Greenberg NM, Fenster A. Molecular targeted enhanced ultrasound imaging of Flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model. Mol Imaging 8, 209-220 (2009)
  • 6. Applications
  • Akpinar E, Turkbey B, Karcaaltincaba M, Balli O, Akkapulu N, Balas S, Tirnaksiz B, Akata D, Akhan O. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis. J Magn Reson Imaging 30, 578-585 (2009)
  • Amano Y, Takayama M, Kumita S. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy. J Magn Reson Imaging 30, 778-784 (2009)
  • Frericks BB, Loddenkemper C, Hupperts A, Valdeig S, Stroux A, Seja M, Wolf KJ, Albrecht T. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. Am J Roentgenol 193, 1053-1060 (2009)
  • George M, Shannon M. Intravenous contrast agents and associated changes in serum osmolality. Pediatr Emerg Care 25, 555-557 (2009)
  • Hohmann J, Muller C, Oldenburg A, Skrok J, Frericks BB, Wolf KJ, Albrecht T. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers. Ultrasound Med Biol 35, 1427-1435 (2009)
  • Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: Retrospective review of 456,930 doses. Am J Roentgenol 193, 1124-1127 (2009)
  • Kau T, Gasser J, Celedin S, Rabitsch E, Eicher W, Uhl E, Hausegger KA. MR angiographic follow-up of intracranial aneurysms treated with detachable coils: Evaluation of a blood-pool contrast medium. Am J Neuroradiol 30, 1524-1530 (2009)
  • Kim SM, Haider MA, Milosevic M, Yeung IWT. Interindividual variability of arterial impulse response to intravenous injection of nonionic contrast agent (iohexol) in DCE-CT study. Med Phys 36, 4791-4802 (2009)
  • Lanzani C, Savasi V, Leone FPG, Ratti M, Ferrazzi E. Two-dimensional HyCoSy with contrast tuned imaging technology and a second-generation contrast media for the assessment of tubal patency in an infertility program. Fertil Steril 92, 1158-1161 (2009)
  • Mather AN, Lockie T, Nagel E, Marber M, Perera D, Redwood S, Radjenovic A, Saha A, Greenwood JP, Plein S. Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. J Cardiovasc Magn Reson 11, 33 (2009)
  • Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI. Preoperative evaluation of pancreatic cancer: Comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 30, 586-595 (2009)
  • Shema L, Ore L, Geron R, Kristal B. Contrast-induced nephropathy among Israeli hospitalized patients: Incidence, risk factors, length of stay and mortality. Isr Med Assoc J 11, 460-464 (2009)
  • Truijers M, Futterer JJ, Takahashi S, Heesakkers RA, Blankensteijn JD, Barentz JO. In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent. Am J Roentgenol 193, W437-W441 (2009)
  • Molecular Imaging: 7. Carbon
  • Aalto S, Scheinin NM, Kemppainen NM, Nagren K, Kailajarvi M, Leinonen M, Scheinin M, Rinne JO. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data. Eur J Nucl Med Mol Imaging 36, 1651-1660 (2009)
  • Asai Y, Ikoma Y, Takano A, Maeda J, Toyama H, Yasuno F, Ichimiya T, Ito H, Suhara T. Quantitative analyses of [11C]Ro15-4513 binding to subunits of GABAA/benzodiazepine receptor in the living human brain. Nucl Med Commun 30, 872-880 (2009)
  • Boschi S, Lodi F, Cicoria G, Ledesma JR, Knopp R, Rizzello A, Di Pierro D, Trespidi S, Marengo M. Development of a modular system for the synthesis of PET[11C]labelled radiopharmaceuticals. Appl Radiat Isot 67, 1869-1873 (2009)
  • Dorner B, Kuntner C, Bankstahl JP, Bankstahl M, Stanek J, Wanek T, Stundner G, Mairinger S, Loscher W, Muller M, Langer O, Erker T. Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrier. J Med Chem 52, 6073-6082 (2009)
  • Gao MZ, Wang M, Miller KD, Hutchins GD, Zheng QH. Synthesis of carbon-11 labeled celecoxib derivatives as new candidate PET radioligands for imaging of inflammation. Appl Radiat Isot 67, 2019-2024 (2009)
  • Ishikawa M, Sakata M, Ishii K, Kimura Y, Oda K, Toyohara J, Wu J, Ishiwata K, Iyo M, Hashimoto K. High occupancy of σ1 receptors in the human brain after single oral administration of donepezil: A positron emission tomography study using [11C]SA4503. Int J Neuropsychopharmacol 12, 1127-1131 (2009)
  • Kato K, Schober O, Ikeda M, Schafers M, Ishigaki T, Kies P, Naganawa S, Stegger L. Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging 36, 1622-1628 (2009)
  • Marton J, Schoultz BW, Hjornevik T, Drzezga A, Yousefi BH, Wester HJ, Willoch F, Henriksen G. Synthesis and evaluation of a full-agonist orvinol for PET imaging of opioid receptors: [11C] PEO. J Med Chem 52, 5586-5589 (2009)
  • McCormick PN, Kapur S, Reckless G, Wilson AA. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro. Synapse 63, 998-1009 (2009)
  • Mikecz P, Marian T, Miklovicz T, Galuska L, Krasznai Z, Toth A, Goda K, Tron L, Hernadi Z, Krasznai ZT. Daunorubicin and doxorubicin inhibit the [11C]choline accumulation in cancer cells. Appl Radiat Isot 67, 1806-1811 (2009)
  • Nyberg S, Jonhagen ME, Cselenyi Z, Halldin C, Julin P, Olsson H, Freund-levi Y, Andersson J, Varnas K, Svensson S, Farde L. Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184. Eur J Nucl Med Mol Imaging 36, 1859-1863 (2009)
  • Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Nagren K, Bullock R, Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ. Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study. Neurology 73, 754-760 (2009)
  • Rinnab L, Simon J, Hautmann RE, Cronauer MV, Hohl K, Buck AK, Reske SN, Mottaghy FM. [11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy. World J Urol 27, 619-625 (2009)
  • Scheinin NM, Aalto S, Koikkalainen J, Lotjonen J, Karrasch M, Kemppainen N, Viitanen M, Nagren K, Helin S, Scheinen M, Rinne JO. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls. Neurology 73, 1186-1192 (2009)
  • Shibata H, Nomori H, Uno K, Iyama K, Tomiyoshi K, Nakashima R, Sakaguchi K, Goya T, Takanami I, Koizumi K, Suzuki T, Kaji M, Horio H. 11C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma: Comparison with 18F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness. Ann Nucl Med 23, 609-616 (2009)
  • Smith DF, Stork BS, Wegener G, Ashkanian M, Jakobsen S, Bender D, Audrain H, Vase KH, Hansen SB, Videbech P, Rosenberg R. [11C]Mirtazapine binding in depressed antidepressant nonresponders studied by PET neuroimaging. Psychopharmacology (Berl) 206, 133-140 (2009)
  • Takahashi H, Haga Y, Shibata T, Nonoshita K, Sakamoto T, Moriya M, Ohe T, Chiba M, Mitobe Y, Kitazawa H, Iwaasa H, Ishihara A, Ishii Y, Kanatani A, Fukami T. Identification of positron emission tomography ligands for NPY Y5 receptors in the brain. Bioorg Med Chem Lett 19, 5436-5439 (2009)
  • Tolboom N, Yaqub M, Boellaard R, Luurtsema G, Windhorst AD, Scheltens P, Lammertsma AA, Van Berckel BNM. Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease. Eur J Nucl Med Mol Imaging 36, 1629-1638 (2009)
  • Wang M, Yoder KK, Gao MZ, Mock BH, Xu XM, Saykin AJ, Hutchins GD, Zheng QH. Fully automated synthesis and initial PET evaluation of [11C]PBR28. Bioorg Med Chem Lett 19, 5636-5639 (2009)
  • Williams TM, Davies SJC, Taylor LG, Daglish MRC, Hammers A, Brooks DJ, Nutt DJ, Lingford-Hughes A. Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study. Eur Neuropsychopharmacol 19, 740-748 (2009)
  • Wilson AA, Garcia A, Houle S, Vasdev N. Utility of commercial radiosynthetic modules in captive solvent [11C]-methylation reactions. J Labelled Comp Radiopharm 52, 490-492 (2009)
  • Yamasaki T, Kumata K, Yanamoto K, Hatori A, Takei M, Nakamura Y, Koike S, Ando K, Suzuki K, Zhang MR. Imaging of peripheral-type benzodiazepine receptor in tumor: In vitro binding and in vivo biodistribution of N-benzyl-N-[11C]methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide. Nucl Med Biol 36, 801-809 (2009)
  • Yanamoto K, Yamasaki T, Kumata K, Yui J, Odawara C, Kawamura K, Hatori A, Inoue O, Yamaguchi M, Suzuki K, Zhang MR. Evaluation of N-benzyl-N-[11C]methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl) acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat. Synapse 63, 961-971 (2009)
  • Yang J, Johnson C, Shen J. Detection of reduced GABA synthesis following inhibition of GABA transaminase using in vivo magnetic resonance signal of [13C]GABA C1. J Neurosci Methods 182, 236-243 (2009)
  • Yoshii Y, Waki A, Furukawa T, Kiyono Y, Mori T, Yoshii H, Kudo T, Okazawa H, Welch MJ, Fujibayashi Y. Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: Implications for the mechanism of acetate PET. Nucl Med Biol 36, 771-777 (2009)
  • 8. Fluorine
  • Aukema TS, Olmos RAV, Klomp HM, Teertstra HJ, Belderbos JSA, Vogel WV, Baas P, Burgers SA, Van den Heuvel MM. Evaluation of 18F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment. J Thorac Oncol 4, 1226-1230 (2009)
  • Black NF, McJames S, Kadrmas DJ. Rapid multi-tracer PET tumor imaging with 18F-FDG and secondary shorter-lived tracers. IEEE Trans Nucl Sci 56, 2750-2758 (2009)
  • Blom E, Karimi F, Langstrom B. [18F]/19F exchange in fluorine containing compounds for potential use in 18F-labelling strategies. J Labelled Comp Radiopharm 52, 504-511 (2009)
  • Bruechner K, Bergmann R, Santiago A, Mosch B, Yaromina A, Hessel F, Hofheinz F, Van den Hoff J, Baumann M, Beuthien-Baumann B. Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation. Int J Radiat Biol 85, 772-780 (2009)
  • Carlin S, Pugachev A, Sun XR, Burke S, Claus F, O'Donoghue J, Ling CC, Humm JL. In vivo characterization of a reporter gene system for imaging hypoxia-induced gene expression. Nucl Med Biol 36, 821-831 (2009)
  • Choi SJ, Kim SY, Kim SJ, Lee JS, Lee SJ, Park SA, Lee SJ, Yun SC, Im KC, Oh SJ, Kim SW, Kim JS, Ryu JS, Moon DH. Reproducibility of the kinetic analysis of 3′-deoxy-3′-[18F] fluorothymidine positron emission tomography in mouse tumor models. Nucl Med Biol 36, 711-719 (2009)
  • Debucquoy A, Devos E, Vermaelen P, Landuyt W, De Weer S, Van den Heuvel F, Haustermans K. 18F-FLT and 18F-FDG PET to measure response to radiotherapy combined with celecoxib in two colorectal xenograft models. Int J Radiat Biol 85, 763-771 (2009)
  • Dotti G, Tian M, Savoldo B, Najjar A, Cooper LJN, Jackson J, Smith A, Mawlawi O, Uthamanthil R, Borne A, Brammer D, Paolillo V, Alauddin M, Gonzalez C, Steiner D, Decker WK, Marini F, Kornblau S, Bollard CM, Shpall EJ, Gelovani JG. Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU. Mol Imaging 8, 230-237 (2009)
  • Duch J, Fuster D, Munoz M, Fernandez PL, Paredes P, Fontanillas M, Guzman F, Rubi S, Lomena FJ, Pons F. 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. Eur J Nucl Med Mol Imaging 36, 1551-1557 (2009)
  • Fiebrich HB, Brouwers AH, Kerstens MN, Pijl MEJ, Kema IP, De Jong JR, Jager PL, Elsinga PH, Dierckx RAJO, Van der Wal JE, Sluiter WJ, De Vries EG, Links TP. 6-[18F]fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with 123I-metaiodobenzylguanidine scintigraphy, computer tomography and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab 94, 3922-3930 (2009)
  • Fu YK, Chang CJ, Chen KY, Hwang LC, Wu KH, Chang KW, Jan ML, Chen CC, Chang CH. Imaging of regional metabolic activity by 18F-FDG/PET in rats with transient cerebral ischemia. Appl Radiat Isot 67, 1743-1747 (2009)
  • Gagnon MKJ, Hausner SH, Marik J, Abbey CK, Marshall JF, Sutcliffe JL. High-throughput in vivo screening of targeted molecular imaging agents. Proc Natl Acad Sci U S A 106, 17904-17909 (2009)
  • Gill HS, Tinianow JN, Ogasawara A, Flores JE, Vanderbilt AN, Raab H, Scheer JM, Vandlen R, Williains SP, Marik J. A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2. J Med Chem 52, 5816-5825 (2009)
  • Greguric I, Taylor SR, Denoyer D, Ballantyne P, Berghofer P, Roselt P, Pham TQ, Mattner F, Bourdier T, Neels OC, Dorow DS, Loc'h C, Hicks RJ, Katsifis A. Discovery of [18F]N-(2-(diethylamino)ethyl)-6-fluoronicotinamide: A melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance. J Med Chem 52, 5299-5302 (2009)
  • Han B, Lin S, Yu LJ, Wang RZ, Wang YY. Correlation of 18F-FDG PET activity with expressions with survivin, Ki67, and CD34 in non-small-cell lung cancer. Nucl Med Commun 30, 831-837 (2009)
  • Hara T, Higashi T, Nakamoto Y, Suga T, Saga T, Ishimori T, Ishizu K, Kawashima H, Kawase S, Matsumoto K, Togashi K. Significance of chronic marked hyperglycemia on FDG-PET: Is it really problematic for clinical oncologic imaging?. Ann Nucl Med 23, 657-669 (2009)
  • Holschbach MH, Bier D, Wutz W, Willbold S, Olsson RA. Synthesis of the main metabolite in human blood of the A1 adenosine receptor ligand [18F]CPFPX. Org Lett 11, 4266-4269 (2009)
  • Holtke C, Law MP, Wagner S, Kopka K, Faust A, Breyholz HJ, Schober O, Bremer C, Riemann B, Schafers M. PET-compatible endothelin receptor radioligands: Synthesis and first in vitro and in vivo studies. Bioorg Med Chem 17, 7197-7802 (2009)
  • Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, Siegel C, Cao DF, Gao F, Siegel BA. Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 27, 4314-4320 (2009)
  • Kobus D, Giesen Y, Ullrich R, Backes H, Neumaier B. A fully automated two-step synthesis of an 18F-labelled tyrosine kinase inhibitor for EGFR kinase activity imaging in tumors. Appl Radiat Isot 67, 1977-1984 (2009)
  • Krug B, Van Zanten A, Pirson AS, Crott R, Vander Borght T. Activity-based costing evaluation of a [18F]-fludeoxyglucose positron emission tomography study. Health Policy 92, 234-243 (2009)
  • Kruger S, Buck AK, Mottaghy FM, Hasenkamp E, Pauls S, Schumann C, Wibmer T, Merk T, Hombach V, Reske SN. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 36, 1807-1812 (2009)
  • Lee JW, Kang KW, Park SH, Lee SM, Paeng JC, Chung JK, Lee MC, Lee DS. 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging 36, 1574-1582 (2009)
  • Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, Kang WJ. 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: Consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging 36, 1794-1802 (2009)
  • Leyton J, Smith G, Zhao YJ, Perumal M, Nguyen QD, Robins E, Arstad E, Aboagye EO. [18F]Fluoromethyl-[1,2-2H4]-choline: A novel radiotracer for imaging choline metabolism in tumors by positron emission tomography. Cancer Res 69, 7721-7728 (2009)
  • Li Z, Li QZ, Pantazis D, Yu XL, Conti PS, Leahy RM. Controlling familywise error rate for matched subspace detection in dynamic FDG PET. IEEE Trans Med Imaging 28, 1623-1631 (2009)
  • Liao CT, Chang JTC, Wang HM, Ng SH, Huang SF, Chen IH, Hsueh C, Lee LY, Lin CH, Cheng AJ, Yen TC. Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse. Eur J Nucl Med Mol Imaging 36, 1783-1793 (2009)
  • Litmanovich D, Gourevich K, Israel O, Gallimidi Z. Unexpected foci of 18F-FDG uptake in the breast detected by PET/CT: Incidence and clinical significance. Eur J Nucl Med Mol Imaging 36, 1558-1564 (2009)
  • Magini G, Farsad M, Frigerio M, Serra C, Colecchia A, Jovine E, Vivarelli M, Feletti V, Golfieri R, Patti C, Fanti S, Franchi R, Lodi F, Boschi S, Bernardi M, Trevisani F. 11C acetate does not enhance usefulness of 18F FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med 34, 659-665 (2009)
  • Massarweh G, Kovacevic M, Rosa-Neto P, Evans AC, Diksic M, Schirrmacher R. Time-efficient and convenient synthesis of [18F]altanserin for human PET imaging by a new work-up procedure. Appl Radiat Isot 67, 2040-2043 (2009)
  • Massaweh G, Schirrmacher E, La Fougere C, Kovacevic M, Wangler C, Jolly D, Gravel P, Reader AJ, Thiel A, Schirrmacher R. Improved work-up procedure for the production of [18F]flumazenil and first results of its use with a high-resolution research tomograph in human stroke. Nucl Med Biol 36, 721-727 (2009)
  • Moraes AB, Taboada GF, Carneiro MP, Neto LV, Wildemberg LEA, Madi K, Domingues RC, Gadelha MR. Utility of [18F] fluoro-2-deoxy-D-glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors. Pituitary 12, 380-383 (2009)
  • Mou TT, Yang WJ, Peng C, Zhang XZ, Ma YC. [18F]-labeled 2-methoxyphenylpiperazine derivative as a potential brain positron emission tomography imaging agent. Appl Radiat Isot 67, 2013-2018 (2009)
  • Nguyen QD, Smith G, Glaser M, Perumal M, Arstad E, Aboagye EO. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Proc Natl Acad Sci U S A 106, 16375-16380 (2009)
  • Pauleit D, Stoffels G, Bachofner A, Floeth FW, Sabel M, Herzog H, Tellmann L, Jansen P, Reifenberger G, Hamacher K, Coenen HH, Langen KJ. Comparison of 18F-FET and 18F-FDG PET in brain tumors. Nucl Med Biol 36, 779-787 (2009)
  • Postema EJ, McEwan AJB, Riauka TA, Kumar P, Richmond DA, Abrams DN, Wiebe LI. Initial results of hypoxia imaging using 1-α-D-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA). Eur J Nucl Med Mol Imaging 36, 1565-1573 (2009)
  • Riss PJ, Debus F, Hummerich R, Schmidt U, Schloss P, Lueddens H, Roesch F. Ex vivo and in vivo evaluation of [18F]PRO4.MZ in rodents: A selective dopamine transporter imaging agent. ChemMedChem 4, 1480-1487 (2009)
  • Salaun PY, Gatinne T, Bodet-Milin C, Campion L, Cambefort P, Moreau A, Le Gouill S, Berthou C, Moreau P, Kraeber-Bodere F. Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: A reflection of disease infiltration or just inflammation?. Eur J Nucl Med Mol Imaging 36, 1813-1821 (2009)
  • Santhosh L, Estok KM, Vogel RS, Tamagnan GD, Baldwin RM, Mitsis EM, MacAvoy MG, Staley JK, Van Dyck CH. Regional distribution and behavioral correlates of 5-HT2A receptors in Alzheimer's disease with [18F]deuteroaltanserin and PET. Psychiatr Res Neuroimaging 173, 212-217 (2009)
  • Serdons K, Vanderghinste D, Van Eeckhoudt M, Borghgraef P, Kung H, Van Leuven F, De Groot T, Bormans G, Verbruggen A. Synthesis and evaluation of two fluorine-18 labelled phenylbenzothiazoles as potential in vivo tracers for amyloid plaque imaging. J Labelled Comp Radiopharm 52, 473-481 (2009)
  • Strobel K, Bode B, Dummer R, Veit-Haibach P, Fischer DR, Imhof L, Goldinger S, Steinert HC, Von Schulthess GK. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging 36, 1774-1782 (2009)
  • Takano A, Gulyas B, Varrone A, Halldin C. Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER. Eur J Nucl Med Mol Imaging 36, 1885-1891 (2009)
  • Takaoka Y, Sakamoto T, Tsukiji S, Narazaki M, Matsuda T, Tochio H, Shirakawa M, Hamachi I. Self-assembling nanoprobes that display off/on 19F nuclear magnetic resonance signals for protein detection and imaging. Nat Chem 1, 557-561 (2009)
  • Varrone A, Steiger C, Schou M, Takano A, Finnema SJ, Guilloteau D, Gulyas B, Halldin C. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE21, a new dopamine transporter PET radioligand. Synapse 63, 871-880 (2009)
  • Wang KL, Yorke E, Nehmeh SA, Humm JL, Ling CC. Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET. Med Phys 36, 4400-4408 (2009)
  • Wuest F, Hultsch C, Berndt M, Bergmann R. Direct labeling of peptides with 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG). Bioorg Med Chem Lett 19, 5426-5428 (2009)
  • Yamamoto Y, Kameyama R, Izuishi K, Takebayashi R, Hagiike M, Asakura M, Haba R, Nishiyama Y. Detection of colorectal cancer using 18F-FLT PET: Comparison with 18F-FDG PET. Nucl Med Commun 30, 841-845 (2009)
  • Yu M, Guaraldi MT, Bozek J, Kagan M, Azure M, Radeke H, Cdebaca M, Robinson SP. Effects of food intake and anesthetic on cardiac imaging and uptake of BMS747158-02 in comparison with FDG. J Nucl Cardiol 16, 763-768 (2009)
  • Jain D, Ghanbarinia A, He ZX. Developing a new PET myocardial perfusion tracer (Comment on above). J Nucl Cardiol 16, 689-690 (2009)
  • Zhang X, Paule MG, Newport GD, Zou XJ, Sadovova N, Berridge MS, Apana SM, Hanig JP, Slikker W, Wang C. A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: MicroPET imaging using 18F-annexin V. Toxicol Sci 111, 355-361 (2009)
  • 10. Hydrogen
  • Khare P, White AR, Parsons SM. Multiple protonation states of vesicular acetylcholine transporter detected by binding of [3H] vesamicol. Biochemistry 48, 8965-8975 (2009)
  • 11. Indium
  • Kwekkeboom DJ, Krenning EP, Scheidhauer K, Lewington V, Lebtahi R, Grossman A, Vitek P, Sundin A, Plockinger U. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Somatostatin receptor imaging with 111In-pentetreotide. Neuroendocrinology 90, 184-189 (2009)
  • Newton-Northup JR, Figueroa SD, Quinn TP, Deutscher SL. Bifunctional phage-based pretargeted imaging of human prostate carcinoma. Nucl Med Biol 36, 789-800 (2009)
  • 12. Iodine
  • Donohue SR, Varnas K, Jia ZS, Gulyas B, Pike VW, Halldin C. Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors. Bioorg Med Chem Lett 19, 6209-6212 (2009)
  • Sata N, Kawano T, Hamada N, Horinouchi T, Amitani S, Moriyama Y, Miyahara K. Predictor of underlying myocardial damage in normally functioning left ventricle with narrow QRS complex: Relationship between QRD duration at right ventricle pacing and iodine-123 metaiodobenzylguanidine myocardial scintigraphy. Ann Nucl Med 23, 639-641 (2009)
  • Schmitt GJE, Meisenzahl EM, Frodl T, La Fougere C, Hahn K, Moller HJ, Dresel S. Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [123I]IBZM SPECT. Psychiatr Res Neuroimaging 173, 183-189 (2009)
  • Stahischmidt A, Khalili P, Sun W, Machulla HJ, Knaus EE, Wiebe LI. Biodistribution and imaging of 1-(2-deoxy-β-D-ribofuranosyl)-2,4-difluoro-5-[123/125I]iodobenzene (dRF[123/125I]IB), a nonpolar thymidine-mimetic nucleoside, in rats and tumor-bearing mice. Nucleosides Nucleotides Nucleic Acids 28, 379-393 (2009)
  • 14. Technetium
  • Ahn BC, Kim HJ, Lee SW, Yoo J, Choi JK, Lee J. New quantitative method for bone tracer uptake of temporomandibular joint using 99mTc MDP skull SPECT. Ann Nucl Med 23, 651-656 (2009)
  • Amir N, Roohi S, Mushtaq A, Pervez S, Saeed S. Comparative studies of S-bridged complexes of 99mTc with fac(S)-[M(aet)3] (M = RhIII, IrIII; aet = 2-aminoethanethiolate). Radiochim Acta 97, 507-512 (2009)
  • Bateman TM, Heller GV, McGhie AI, Courter SA, Golub RA, Case JA, Cullom SJ. Multicenter investigation comparing a highly efficient half-time stress-only attenuation correction approach against standard rest-stress 99mTc SPECT imaging. J Nucl Cardiol 16, 726-735 (2009)
  • Bertagna F, Barozzi O, Puta E, Lucchini S, Paghera B, Savelli G, Panarotto B, Rodella CA, Rebuffoni L, Bosio G, Terzi A, Giubbini R. Residual brain viability, evaluated by 99mTc-ECD SPECT, in patients with suspected brain death and with confounding clinical factors. Nucl Med Commun 30, 815-821 (2009)
  • Bourkoula A, Paravatou-Petsotas M, Papadopoulos A, Santos I, Pietzsch HJ, Livaniou E, Pelecanou M, Papadopoulos M, Pirmettis I. Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging. Eur J Med Chem 44, 4021-4027 (2009)
  • Fu Y, Letourneau M, Nguyen QT, Chatenet D, Dupuis J, Fournier A. Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging. Eur J Pharmacol 617, 118-123 (2009)
  • Haider N, Hartung D, Fujimoto S, Petrov A, Kolodgie FD, Virmani R, Ohshima S, Liu H, Zhou J, Fujimoto A, Tahara A, Hofstra L, Narula N, Reutelingsperger C, Narula J. Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: Molecular imaging facilitates understanding of pathogenesis. J Nucl Cardiol 16, 753-762 (2009)
  • Ibrahim IT. Preparation of 99mTc-metronidazole as a model for tumor imaging. J Radioanal Nucl Chem 281, 669-674 (2009)
  • Mirtschink P, Stehr SN, Walther M, Pietzsch J, Bergmann R, Pietzsch HJ, Weichsel J, Pexa A, Dietrich P, Wunderlich G, Binas B, Kropp J, Deussen A. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging Part 1: Myocardial extraction and biodistribution. Nucl Med Biol 36, 833-843 (2009)
  • Mirtschink P, Stehr SN, Walther M, Pietzsch J, Bergmann R, Pietzsch HJ, Weichsel J, Pexa A, Dietrich P, Wunderlich G, Binas B, Kropp J, Deussen A. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging Part 2. Subcellular distribution. Nucl Med Biol 36, 845-852 (2009)
  • Pervez S, Mushtaq A. Formulation of a freeze-dried kit for the preparation of 99mTc-tetrofosmin. J Radioanal Nucl Chem 281, 371-377 (2009)
  • Schechter NR, Erwin WD, Yang DJ, Kim EE, Munden RF, Forster K, Taing LC, Cox JD, Macapinlac HA, Podoloff DA. Radiation dosimetry and biodistribution of 99mTc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 36, 1583-1591 (2009)
  • Shi JY, Wang LJ, Kim YS, Zhai SZ, Jia B, Wang F, Liu S. 99mTcO(MAG2-3G3-dimer): A new integrin αvβ3-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics. Eur J Nucl Med Mol Imaging 36, 1874-1884 (2009)
  • Song SH, Kwak IS, Kim SJ, Kim YK, Kim IJ. Depressive mood in pre-dialytic chronic kidney disease: Statistical parametric mapping analysis of 99mTc ECD brain SPECT. Psychiatr Res Neuroimaging 173, 243-247 (2009)
  • Tran TA, Rosik D, Abrahmsen L, Sandstrom M, Sjoberg A, Wallberg H, Ahlgren S, Orlova A, Tolmachev V. Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging. Eur J Nucl Med Mol Imaging 36, 1864-1873 (2009)
  • Xiong CY, Lu W, Zhang R, Tian M, Tong W, Gelovani J, Li C. Cell-permeable [99mTc(CO3)]-labeled fluorogenic caspase 3 substrate for dual-modality detection of apoptosis. Chemistry 15, 8979-8984 (2009)
  • Zhang H, Jiang NY, Zhu L. Experimental studies on imaging of infected site with 99mTc-labeled ciprofloxacin in mice. Chin Med J 122, 1907-1909 (2009)
  • 15. Others
  • Badr CE, Niers JM, Tjon-Kon-Fat LA, Noske DP, Wurdinger T, Tannous BA. Real-time monitoring of nuclear factor κB activity in cultured cells and in animal models. Mol Imaging 8, 278-290 (2009)
  • Chen N, Huang Y, Yang LL, Liu RH, Yang JJ. Designing caspase-3 sensors for imaging of apoptosis in living cells. Chemistry 15, 9311-9314 (2009)
  • Choi Y, Kim HP, Hong SM, Ryu JY, Han SJ, Song R. In situ visualization of gene expression using polymer-coated quantum-dot-DNA conjugates. Small 5, 2085-2091 (2009)
  • Devaraj NK, Upadhyay R, Hatin JB, Hilderbrand SA, Weissleder R. Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. Angew Chem Int Ed 48, 7013-7016 (2009)
  • Dyrager C, Friberg A, Dahlen K, Friden-Saxin M, Borjesson K, Wilhelmsson LM, Smedh M, Grotli M, Luthman K. 2,6,8-Trisubstituted 3-hydroxychromone derivatives as fluorophores for live-cell imaging. Chemistry 15, 9417-9423 (2009)
  • Flors C, Ravarani CNJ, Dryden DTF. Super-resolution imaging of DNA labelled with intercalating dyes. ChemPhysChem 10, 2201-2204 (2009)
  • Jost SC, Collins L, Travers S, Piwnica-Worms D, Garbow JR. Measuring brain tumor growth: Combined bioluminescence imaging-magnetic resonance imaging strategy. Mol Imaging 8, 245-253 (2009)
  • Kim DE, Kim JY, Schellingerhout D, Shon SM, Jeong SW, Kim EJ, Kim WK. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine. Mol Imaging 8, 291-301 (2009)
  • Kimball KJ, Rivera AA, Zinn KR, Icyuz M, Saini V, Li J, Zhu ZB, Siegal GR, Douglas JT, Curiel DT, Alvarez RD, Borovjagin AV. Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer. Mol Imaging 8, 264-277 (2009)
  • Lee H, Akers WJ, Cheney PP, Edwards WB, Liang KX, Culver JP, Achilefu S. Complementary optical and nuclear imaging of caspase-3 activity using combined activatable and radio-labeled multimodality molecular probe. J Biomed Opt 14, 040507 (2009)
  • Liu W, Hao GY, Long MA, Anthony T, Hsieh JT, Sun XK. Imparting multivalency to a bifunctional chelator: A scaffold design for targeted PET imaging probes. Angew Chem Int Ed 48, 7346-7349 (2009)
  • Matsumoto S, Tanaka F, Sato K, Kimura S, Maekawa T, Hasegawa S, Wada H. Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma. Lung Cancer 66, 75-79 (2009)
  • Nakata E, Yukimachi Y, Kariyazono H, Im S, Abe C, Uto Y, Maezawa H, Hashimoto T, Okamoto Y, Hori H. Design of a bioreductively-activated fluorescent pH probe for tumor hypoxia imaging. Bioorg Med Chem 17, 6952-6958 (2009)
  • Nesterov SV, Han CL, Maki M, Kajander S, Naum AG, Helenius H, Lisinen I, Ukkonen H, Pietila M, Joutsiniemi E, Knuuti J. Myocardial perfusion quantitation with 15O-labelled water PET: High reproducibility of the new cardiac analysis software (Carimas™). Eur J Nucl Med Mol Imaging 36, 1594-1602 (2009)
  • Rosol M, Harutyunyan I, Xu J, Melendez E, Smbatyan G, Finlay JL, Krieger MD, Gonzalez-Gomez I, Reynolds CP, Nelson MD, Erdreich-Epstein A, Bluml S. Metabolism of orthotopic mouse brain tumor models. Mol Imaging 8, 199-208 (2009)
  • Tan XB, Wang ZY, Yang J, Song CY, Zhang RH, Cui YP. Polyvinylpyrrolidone- (PVP-) coated silver aggregates for high performance surface-enhanced Raman scattering in living cells. Nanotechnology 20, 445102 (2009)
  • Visnapuu ML, Greene EC. Single-molecule imaging of DNA curtains reveals intrinsic energy landscapes for nucleosome deposition. Nat Struct Mol Biol 16, 1056-1062 (2009)
  • Zhou J, Soontornworajit B, Martin J, Sullenger BA, Gilboa E, Wang Y. A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling. Macromol Biosci 9, 831-835 (2009)